ONCOLYS BIOPHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 706 JPY | -0.56% |
|
+1.15% | +24.51% |
Chart calendar Oncolys BioPharma Inc.
536ed3adcbc86dae97ffd.FFJsIAPlc_RFXFR3H4QO0FHEFNrnTLUpu8lLuE1U2YU.IDwdEXWHKsIpExYEQMpLnQKlXKPXeed99K8U4gNsl_ZGKg56aNc5hnI-bA~b83e30d993b03787ad974c58bc4dbdd0
Upcoming events on Oncolys BioPharma Inc.
Past events on Oncolys BioPharma Inc.
| 2024-02-08 | Q4 2023 Earnings Release |
| 2023-11-09 | Q3 2023 Earnings Release |
| 2023-08-03 | Q2 2023 Earnings Release |
| 2023-05-11 | Q1 2023 Earnings Release |
| 2023-02-09 | Q4 2022 Earnings Release |
| 2022-11-03 | Q3 2022 Earnings Release |
| 2022-08-04 | Interim 2022 Earnings Release |
| 2022-05-12 | Q1 2022 Earnings Release |
| 2022-02-09 | FY 2021 Earnings Release |
| 2021-11-04 | Q3 2021 Earnings Release |
| 2021-08-05 | Interim 2021 Earnings Release |
| 2021-05-06 | Q1 2021 Earnings Release |
| 2021-02-11 | FY 2020 Earnings Release |
| 2020-11-05 | Q3 2020 Earnings Release |
| 2020-08-06 | Interim 2020 Earnings Release |
| 2020-05-07 | Q1 2020 Earnings Release |
| 2019-10-31 | Q3 2019 Earnings Release |
| 2019-08-01 | Interim 2019 Earnings Release |
| 2019-05-09 | Q1 2019 Earnings Release |
| 2019-02-07 | FY 2018 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 168 230 -26.96% | 1 303 1 200 8.58% | 314 300 4.67% | 642 400 60.5% | 976 | 63,0 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million JPY | Released Forecast Spread | -1 247 -1 400 10.93% | -511 -400 -27.75% | -1 674 -1 200 -39.5% | -1 454 -1 800 19.22% | -1 204 | -1 929 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -1 230 0,00 - | -908 0,00 - | -2 091 0,00 - | -1 611 0,00 - | -1 146 | -1 935 |
|
Net income Million JPY | Released Forecast Spread | -1 233 -1 400 11.93% | -912 -400 -128% | -2 095 -1 200 -74.58% | -1 615 -1 800 10.28% | -1 148 | -1 938 |
|
EPS JPY | Released Forecast Spread | -105 -118 11.7% | -65,6 -29,0 -126.03% | -146 -83,4 -74.56% | -95,5 -113 15.34% | -66,3 | -109 |
| Announcement Date | 08/02/19 | 07/02/20 | 12/02/21 | 10/02/22 | 10/02/23 | 09/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q1 | 2021 Q3 | 2022 Q1 | 2022 Q3 | 2023 Q1 |
|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 62,0 | 125 | 193 | 358 | 35,0 |
|
EBIT Million JPY | Released Forecast Spread | -349 | -330 | -384 | -279 | -325 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -349 | -327 | -328 | -264 | -322 |
|
Net income Million JPY | Released Forecast Spread | -350 | -329 | -328 | -265 | -323 |
|
EPS JPY | Released Forecast Spread | -22,4 | -19,0 | -19,0 | -15,3 | -18,7 |
| Announcement Date | 07/05/21 | 05/11/21 | 13/05/22 | 04/11/22 | 12/05/23 |
| 2024-05-06 07:00 am | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | BIOTEST AG: Q1 2024 Earnings Release |
| 2024-05-06 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 02:00 am | BIOGAIA AB: Q1 2024 Earnings Release |
| 2024-05-07 07:30 am | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 2024-05-08 07:55 am | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 2024-05-08 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for Oncolys BioPharma Inc.
| 2024-05-02 04:05 pm | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 2024-05-02 07:50 am | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:30 am | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-30 07:00 am | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 2024-04-29 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-29 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-29 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
| 2024-04-29 05:53 pm | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
| 2024-04-28 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4588 Stock
- Calendar Oncolys BioPharma Inc.
